美国 Thermo Fisher Lab Vision 
Themro旗下的NeoMarkers (Lab Vision & NEOMARKERS) 公司在免疫组织化学产品领域上处于世界领先水平。Lab Vision & NEOMARKERS从研究与临床需要出发，设计开发产品，真正满足实际要求，产品已被生命科学研究群体所广泛认同；有完善的专业文献资料积累，所有产品都提供详细的技术资料与重要的相关文献；产品提供多种规格，单抗有0.1ml和1.0ml与即用型（7ml）以及纯化的抗体（试用型20ug，100ug与200ug），可以适应各种不同要求，此外还可根据实验要求选择特定的产品形式或规格。
主要产品线如下：
一抗：
产品线拥有近2000种一抗,包括肿瘤标志物、细胞因子、细胞凋亡、信号转导等，多数抗体可用于石蜡切片的免疫组化检测。
UltraVision二抗系统：
组化体系非常先进，使用便捷，灵敏度高，您进行组织切片检测与处理的理想选择。
此外，还提供抗原修复等免疫组织化学辅助产品。



About Lab Vision We are part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings.

Lab Vision

Lab Vision now part of Thermo Fisher Scientific was founded in 1994 as an employee-owned biotech manufacturing company and acquired by Sybron International in August 2000. (Sybron spun-off their laboratory products division as Apogent Technologies in December 2000). Located in Fremont, California (USA), Lab Vision is situated in the epicenter of high-tech and biotechnology. We focus on state-of-the-art automation and reagents to meet customer needs. Lab Vision's acquisition of NEOMARKERS in 2002 strengthened our ability to better meet the needs of customers. NEOMARKERS was established in the early nineties by a scientist with over 20 years of experience in cancer research. In August 2004, Lab Vision' parent company Apogent Technologies merged with Fisher Scientific.

Lab Vision's ability to offer unrivaled instrumentation development, innovative histology reagent manufacturing, cutting-edge antibody product offerings, and customer/technical support that go the extra mile has made Lab Vision a leader in the clinical and research markets. The patented* Lab Vision AutostainerTM has revolutionized automated immunohistochemistry. Lab Vision's staff of engineers covers all relevant fields of expertise, including computer software. The Lab Vision AutostainerTM is controlled by a proprietary software program developed in-house by Lab Vision's experts. As a high quality, totally open system (allowing the user free choice of reagents), the Lab Vision AutostainerTM represents a customer-oriented concept for automation in Immunohistochemistry. (* Patent Nos. 5,839,091; 6,349,264; 6,735,531)

Lab Vision also manufactures UltraVision detection systems, synonymous with innovative Immunohistochemistry. These detection systems offer the latest technology and value in enzyme Immunohistochemistry. The UltraVision polymer systems offer high sensitivity while, the UltraVision biotin-streptavidin systems offer affordability. Made from the highest quality immunological and biochemical components, UltraVision is ideal for routinely processed surgical specimens. The systems are quick and easy to use. The UltraVision product line is a perfect compliment to NEOMARKERS antibodies and the Lab Vision AutostainerTM.

NEOMARKERS antibodies come in culture supernatant (0.1ml, 0.5ml and 1.0ml), affinity purified antibodies (0.1ml trial size, 0.5ml and 1ml) and ready-to-use format for use in biochemical applications and histochemical assays respectively.

NEOMARKERS antibodies are already involved in major research studies and are available in custom configurations to fit your unique experimental designs. These include purified antibodies at a higher concentration (1mg/ml) and carrier protein-free and/or sodium azide-free formats. In addition, all antibodies are available in larger quantities for special research projects. Lab Vision and NEOMARKERS are both ISO 13485 and ISO 9001 certified companies with over 50 distributors worldwide.